Featured 13F manager
Sanders Capital, LLC Lewis Sanders
West Palm Beach, FL 26 processed 13Fs on this site · 2021 Q3–2026 Q2
- $99.8B
- 47 Positions
- 2026 Q2
- +18.9% QoQ
- Top 5 41.3%
Portfolio
top 5 41.3% · top 10 60.2%
- TSM - Taiwan Semiconductor 12.5%
- GOOG - Alphabet · CL C 9.7%
- AMZN - Amazon 7.0%
- META - Meta Platforms · CL A 6.1%
- MSFT - Microsoft 6.0%
- NVDA - Nvidia 4.5%
- AMAT - Applied Matls 4.4%
- HCA - Hca Healthcare 3.5%
- STX - Seagate 3.4%
- AAPL - Apple 3.1%
- CI - The Cigna Group 2.8%
- DAL - Delta Air Lines 2.7%
- Other 34.3%
AUM over time
Latest book
| TSM - Taiwan Semiconductor | 12.51% | Reduce −6.8% | 26,149,064 | $477.57 | $12.5B | −1,911,028 | +$3B |
| GOOG - Alphabet · CL C | 9.72% | Reduce −4.4% | 27,472,939 | $353.33 | $9.7B | −1,260,144 | +$1.5B |
| AMZN - Amazon | 7.01% | Reduce −1.6% | 29,352,719 | $238.34 | $7B | −465,956 | +$786M |
| META - Meta Platforms · CL A | 6.11% | Add +2.4% | 10,823,070 | $563.29 | $6.1B | +258,271 | +$52M |
| MSFT - Microsoft | 6.02% | Add +29.9% | 16,102,026 | $373.02 | $6B | +3,708,334 | +$1.4B |
| NVDA - Nvidia | 4.52% | Add +216.6% | 22,560,894 | $200.09 | $4.5B | +15,435,388 | +$3.3B |
| AMAT - Applied Matls | 4.41% | Reduce −1.3% | 6,094,372 | $723.00 | $4.4B | −80,800 | +$2.3B |
| HCA - Hca Healthcare | 3.45% | Reduce −1.4% | 8,828,287 | $389.89 | $3.4B | −128,858 | −$797M |
| STX - Seagate | 3.37% | Reduce −73.0% | 3,487,219 | $965.00 | $3.4B | −9,409,982 | −$1.7B |
| AAPL - Apple | 3.05% | Reduce −3.1% | 10,528,191 | $289.36 | $3B | −341,450 | +$288M |
| CI - The Cigna Group | 2.80% | Reduce −1.4% | 10,144,617 | $275.68 | $2.8B | −145,765 | +$52M |
| DAL - Delta Air Lines | 2.73% | Reduce −1.1% | 29,129,629 | $93.66 | $2.7B | −337,526 | +$769M |
| BAC - Bank of America | 2.65% | Add +2.6% | 46,345,469 | $56.98 | $2.6B | +1,178,310 | +$439M |
| UNH - Unitedhealth Group | 2.46% | Reduce −1.1% | 5,898,634 | $415.63 | $2.5B | −66,051 | +$838M |
| ELV - Elevance | 2.26% | Reduce −1.2% | 5,825,024 | $386.73 | $2.3B | −69,279 | +$527M |
| UAL - United Airls | 2.05% | Reduce −1.2% | 15,027,948 | $135.99 | $2B | −176,603 | +$644M |
| AVGO - Broadcom | 1.95% | New | 5,163,630 | $377.75 | $2B | +5,163,630 | +$2B |
| RTX - Raytheon | 1.76% | Reduce −1.4% | 9,277,878 | $189.73 | $1.8B | −129,400 | −$54M |
| V - VISA · CL A | 1.65% | Reduce −1.3% | 4,796,303 | $343.09 | $1.6B | −65,350 | +$176M |
| SPY — | 1.52% | Reduce −30.3% | 2,036,906 | $746.77 | $1.5B | −886,102 | −$380M |
| CRM - Salesforce | 1.51% | Add +0.9% | 9,615,354 | $156.66 | $1.5B | +83,051 | −$273M |
| DIS - Disney Walt | 1.33% | New | 13,780,700 | $96.25 | $1.3B | +13,780,700 | +$1.3B |
| AZN - Astrazeneca | 1.33% | Reduce −1.1% | 6,986,830 | $189.62 | $1.3B | −78,798 | −$69M |
| BKNG - Booking | 1.32% | Add +2376.0% | 7,414,965 | $178.24 | $1.3B | +7,115,492 | +$1.3B |
| GD - General Dynamics | 1.26% | Reduce −2.0% | 3,546,156 | $354.24 | $1.3B | −71,088 | +$15M |
| JPM - Jpmorgan Chase & | 1.26% | Reduce −1.5% | 3,837,596 | $327.33 | $1.3B | −58,969 | +$110M |
| MA - Mastercard · CL A | 1.20% | Reduce −1.3% | 2,330,359 | $513.60 | $1.2B | −30,070 | +$17M |
| CME - CME Group | 1.12% | Add +21.8% | 5,067,740 | $220.83 | $1.1B | +906,550 | −$110M |
| ULTA - Ulta Beauty | 1.11% | Add +29.0% | 2,460,969 | $450.98 | $1.1B | +552,830 | +$112M |
| LMT - Lockheed Martin | 1.07% | Add +83.5% | 2,093,533 | $509.46 | $1.1B | +952,510 | +$377M |
| PG - Procter & Gamble | 0.98% | Reduce −1.5% | 6,648,957 | $146.64 | $975M | −102,531 | −$182K |
| NOC - Northrop Grumman | 0.93% | Reduce −2.1% | 1,828,249 | $509.31 | $931M | −38,978 | −$343M |
| RCL - Royal Caribbean Group | 0.83% | New | 2,603,252 | $317.53 | $827M | +2,603,252 | +$827M |
| VEU — | 0.66% | Reduce −21.4% | 7,839,638 | $83.75 | $657M | −2,140,071 | −$93M |
| PDD - Pinduoduo | 0.61% | Reduce −1.9% | 7,936,717 | $76.28 | $605M | −155,084 | −$221M |
| TCOM - Trip Group | 0.42% | Reduce −0.8% | 10,560,564 | $39.84 | $421M | −80,210 | −$109M |
| MKC - Mccormick & | 0.41% | New | 8,107,755 | $50.42 | $409M | +8,107,755 | +$409M |
| HSBC — | 0.25% | Reduce −6.2% | 2,632,430 | $95.09 | $250M | −174,600 | +$19M |
| ABBV - Abbvie | 0.12% | Reduce −6.3% | 483,963 | $251.64 | $122M | −32,630 | +$9M |
| ABT - Abbott Laboratories | 0.10% | Reduce −6.3% | 1,050,405 | $90.74 | $95M | −70,800 | −$20M |
| TFC - Truist Finl | 0.10% | Reduce −6.3% | 1,909,022 | $49.82 | $95M | −128,800 | +$1M |
| PEP - Pepsico | 0.07% | Reduce −70.1% | 530,401 | $135.40 | $72M | −1,243,181 | −$204M |
| UL - Unilever | 0.01% | Add +157.2% | 235,435 | $60.12 | $14M | +143,900 | +$9M |
| SHG — | 0.01% | Reduce −21.9% | 119,936 | $63.25 | $8M | −33,690 | −$2M |
| ING - Ing Groep | 0.00% | Reduce −2.7% | 112,785 | $31.38 | $4M | −3,100 | +$520K |
| NWG - Natwest Group | 0.00% | Reduce −2.8% | 179,964 | $17.63 | $3M | −5,100 | +$415K |
| SYF - Synchrony Financial | 0.00% | Reduce −85.3% | 2,773 | $76.05 | $211K | −16,094 | −$1M |
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2026 Q1
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| ACN - Accenture Ireland · CLASS A | 2.65% | Exit | 0 | $198.29 | $2.2B | −11,197,806 | −$2.2B |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 47 | $99.8B | +18.9% | 13F-HR | 8/10/2026 | 000117266126003204 |
| 2026 Q1 | 44 | $83.9B | −3.3% | 13F-HR | 5/14/2026 | 000117266126001934 |
| 2025 Q4 | 44 | $86.8B | +6.8% | 13F-HR | 2/13/2026 | 000117266126000730 |
| 2025 Q3 | 47 | $81.3B | +9.1% | 13F-HR | 11/13/2025 | 000117266125004770 |
| 2025 Q2 | 47 | $74.5B | +11.3% | 13F-HR | 8/8/2025 | 000117266125002985 |
| 2025 Q1 | 47 | $66.9B | −2.2% | 13F-HR | 5/14/2025 | 000117266125001867 |
| 2024 Q4 | 46 | $68.4B | −0.9% | 13F-HR | 2/13/2025 | 000117266125000773 |
| 2024 Q3 | 45 | $69B | +5.7% | 13F-HR | 11/13/2024 | 000117266124004606 |
| 2024 Q2 | 45 | $65.3B | +9.0% | 13F-HR | 8/9/2024 | 000117266124003172 |
| 2024 Q1 | 42 | $59.9B | +10.7% | 13F-HR | 5/10/2024 | 000117266124002130 |
| 2023 Q4 | 44 | $54.1B | +14.3% | 13F-HR | 2/12/2024 | 000117266124000707 |
| 2023 Q3 | 44 | $47.3B | −1.1% | 13F-HR | 11/9/2023 | 000117266123003699 |
| 2023 Q2 | 49 | $47.9B | +13.4% | 13F-HR | 8/11/2023 | 000117266123002910 |
| 2023 Q1 | 48 | $42.2B | +10.6% | 13F-HR | 5/10/2023 | 000117266123001957 |
| 2022 Q4 | 46 | $38.1B | +4.9% | 13F-HR | 2/10/2023 | 000117266123000604 |
| 2022 Q3 | 42 | $36.4B | — | new holds | 2/17/2023 | 000117266123001499 |
| 2022 Q3 | 41 | $36.4B | −8.0% | 13F-HR | 11/14/2022 | 000117266122002493 |
| 2022 Q2 | 42 | $39.5B | −21.3% | 13F-HR | 8/12/2022 | 000117266122001826 |
| 2022 Q1 | 44 | $46B | — | RESTATEMENT | 8/24/2022 | 000117266122002034 |
| 2022 Q1 | 44 | $50.2B | −6.7% | 13F-HR | 5/20/2022 | 000150809722000006 |
| 2021 Q4 | 44 | $49B | — | RESTATEMENT | 8/25/2022 | 000117266122002039 |
| 2021 Q4 | 44 | $53.8B | — | RESTATEMENT | 5/23/2022 | 000150809722000008 |
| 2021 Q4 | 44 | $53.8B | +11.3% | 13F-HR | 2/14/2022 | 000150809722000002 |
| 2021 Q3 | 45 | $44.1B | — | RESTATEMENT | 8/24/2022 | 000117266122002036 |
| 2021 Q3 | 45 | $48.3B | — | RESTATEMENT | 5/24/2022 | 000150809722000016 |
| 2021 Q3 | 45 | $48.3B | — | 13F-HR | 11/12/2021 | 000150809721000005 |
About
Sanders Capital, LLC
26 processed 13Fs on this site · 2021 Q3–2026 Q2